Peptide Legal Status in South Dakota
Minimal restrictions beyond federal guidelines. South Dakota has minimal state-level pharmaceutical oversight beyond federal requirements. Research peptide enforcement is limited due to small regulatory infrastructure.
Key Facts
South Dakota Regulatory Details
Peptide Availability in South Dakota
| Peptide | FDA Status | Evidence | Availability |
|---|---|---|---|
| BPC-157 | Not Approved | C | Accessible |
| TB-500 (Thymosin Beta-4) | Not Approved | C | Accessible |
| GHK-Cu | Not Approved | B | Accessible |
| Ipamorelin | Not Approved | B | Accessible |
| CJC-1295 | Not Approved | B | Accessible |
| Sermorelin | Approved | A | Available by Rx |
| Tesamorelin | Approved | A | Available by Rx |
| Bremelanotide (PT-141) | Approved | A | Available by Rx |
| Semaglutide | Approved | A | Available by Rx |
| Tirzepatide | Approved | A | Available by Rx |
| AOD-9604 | Not Approved | C | Accessible |
| DSIP (Delta Sleep-Inducing Peptide) | Not Approved | D | Accessible |
| Epithalon (Epitalon) | Not Approved | C | Accessible |
| Selank | Not Approved | B | Accessible |
| Semax | Not Approved | B | Accessible |
| GHRP-2 | Not Approved | B | Accessible |
| GHRP-6 | Not Approved | B | Accessible |
| Hexarelin | Not Approved | B | Accessible |
| Melanotan II | Not Approved | C | Accessible |
| LL-37 | Not Approved | C | Accessible |
| Thymalin | Not Approved | C | Accessible |
| KPV | Not Approved | D | Accessible |
| Liraglutide | Approved | A | Available by Rx |
| Retatrutide | Not Approved | B | Accessible |
| Survodutide | Not Approved | B | Accessible |
Peptides in South Dakota: FAQ
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.